ClinicalTrials.gov
public full text
Public Domain
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
This was a prospective, multicentric, randomized, double blind, parallel, saline controlled Phase II clinical study to compare the safety and efficacy of PMZ-1620 (INN: Sovateltide) therapy along with standard supportive care in patients of acute spinal cord injury.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury#881474
- Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke#810906
- Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury#911562
- Pharmacological Agents for Chronic Spinal Cord Injury (SCI)#915442
- Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD#851648
Record · ID 1212067
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive